HEADstrong Foundation Adds Eileen McCay Propp To Board
Cheryl Colleluori, President of the HEADstrong Foundation, announced today that Eileen McCay Propp has joined the Foundation’s board as an advisor.
“We are proud and excited to welcome Eileen to the board,” Colleluori said. “She brings a vast knowledge of the pharmaceutical industry, especially in the oncology space, and will be instrumental in helping us navigate that ever changing industry for those that we assist.”
The associate director of cellular therapy at Bristol-Myers Squibb, McCay Propp assists top academic institutions and highly integrated health systems to build and/or add onto their infrastructure to facilitate the CAR T process.
Throughout her career in the biotech industry, she has managed a portfolio of multibillion-dollar drugs within the hematological and solid tumor space, as well as launching many new products and indications. An award-winning sales manager who builds top performing, cohesive teams that deliver on ambitious goals, McCay Propp serves as the co-lead for the US Commercial Chapter of the BMS Network of Women (BNOW), one of Bristol-Myers Squibb’s employee resource networks. In this role, she has advanced the conversation around gender parity and D&I and focused on providing leadership development and opportunities for diverse collaboration for over 1,000 members nationwide.
McCay Propp earned an MBA with a specialization in executive pharmaceutical marketing from Saint Joseph’s University after completing a bachelor’s degree in marketing from Glassboro State College. She and her husband Brian, a former NHL All-Star and legendary Philadelphia Flyer, have two children.
Founded in 2007 by the late Nicholas Colleluori, the HEADstrong Foundation is relentless in improving the quality of life for those affected by cancer with financial, emotional and residential support including Nick’s House. Discover more about the HEADstrong Foundation, its mission and programs at HEADstrong.org or on social media at @HEADstrongFND.